ALPHA-HYDROXYPHENYLESSIGSÄURE-PHARMAKOPHOR- ODER -BIOISOSTER-MCL-1-PROTEIN-ANTAGONISTEN
European patent · EP3762393 · In force
Register entry
- Publication number
- EP3762393
- Application number
- EP19714512
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 4, 2019
- Published
- Jan 13, 2021
- Granted
- Jan 11, 2023
- Protection ends at the latest
- Mar 3, 2039
- Next annual fee due
- Mar 31, 2027
- IPC classes
- C07D 498/10 (2006.01)C07D 498/20 (2006.01)A61P 35/00 (2006.01)A61K 31/553 (2006.01)C07D 498/22 (2006.01)
- Priority
- US 201862638846 P 05.03.2018
- PCT application
- PCT/US2019/020492 04.03.2019
- PCT publication
- WO2019/173181 12.09.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
- Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
- Apr 1, 2024
Change
Published in Swissreg on 01.04.2024
- Nov 22, 2023
Change
Published in Swissreg on 22.11.2023
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Jan 11, 2023
Granted
Published in Swissreg on 11.01.2023
Parties
Inventor
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
Thousand Oaks, California 91320, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.